Morbid obesity and bariatric surgery
Why examiners ask this
Obesity is in a large share of exam stems, sometimes as the main topic and often as the host disease. Examiners use it to test the airway plan, oxygenation physiology, drug dosing by the right weight, and postoperative disposition when sleep apnea and opioids meet. It stresses application of knowledge and judgment, especially where you send the patient after surgery.
The 60-second answer
My concern is rapid desaturation with a potentially difficult mask and intubation, and postoperative respiratory depression. Preoperatively I screen for obstructive sleep apnea with STOP-BANG,1 look for obesity hypoventilation and pulmonary hypertension, and confirm CPAP comes with the patient. I position ramped, with the external auditory meatus level with the sternal notch, preoxygenate head-up with tight-fitting mask or high-flow nasal oxygen to an end-tidal oxygen above 0.9, and continue apneic oxygenation during laryngoscopy. I use a video laryngoscope and have a second-generation supraglottic airway ready. I ventilate with tidal volumes based on ideal body weight, PEEP, and recruitment. I dose drugs on lean or ideal weight with titration, use multimodal opioid-sparing analgesia, reverse fully, extubate awake and semi-upright, and resume CPAP in recovery.
Decision points and the "why"
- Ramped and head-up — aligns the airway axes and raises functional residual capacity, which extends safe apnea time from about 1–2 minutes to several minutes in a morbidly obese patient.
- Rapid sequence or not — obesity alone does not mandate rapid sequence; gastric volume and pH are similar to lean patients. I use it for reflux, diabetic gastroparesis, GLP-1 receptor agonist use with symptoms or in the dose-escalation phase, or a full stomach on gastric ultrasound.
- GLP-1 agonists — they delay gastric emptying, but the 2024 multisociety guidance lets most patients continue them.2 The highest-risk patients are those in the dose-escalation phase, on higher doses, or with active nausea, vomiting, pain or constipation; I defer elective surgery for escalation or symptoms, ask for a liquid-only diet for 24 hours beforehand, and check gastric ultrasound before induction, treating a full antrum as a full stomach.2
- Dosing scalar — propofol induction and rocuronium on lean body weight; succinylcholine on total body weight because pseudocholinesterase activity and volume of distribution rise;3 sugammadex on actual weight, which in the label's BMI ≥40 trial reversed faster than ideal-weight dosing;4 opioids on lean weight and titrated.
- Ventilation — 6–8 mL/kg ideal body weight, PEEP 8–10 cmH2O or higher with pneumoperitoneum, and recruitment maneuvers, because atelectasis forms within minutes of induction.
- Disposition — continuous pulse oximetry or a monitored bed for untreated or severe OSA, opioid-requiring patients and those with hypoventilation; I do not send a high-risk patient to an unmonitored floor with a PCA.
- VTE prophylaxis — obesity and laparoscopy raise risk; mechanical and pharmacologic prophylaxis and early ambulation.
The complication they will inject
After induction for a sleeve gastrectomy, mask ventilation is difficult and the first video laryngoscopy attempt fails, with the SpO2 at 88% and falling. I call for help, announce the situation, and place a second-generation supraglottic airway to oxygenate rather than make repeated attempts. If oxygenation improves, I decide with the team whether to intubate through it with a flexible scope or to wake the patient. If it fails and I cannot oxygenate, I declare CICO and perform a front-of-neck airway, scalpel-bougie-tube, using a vertical skin incision because landmarks are hard to palpate. I would have reduced this risk with airway ultrasound to mark the cricothyroid membrane before induction.
Pitfalls that cost points
- Dosing all drugs on total body weight.
- Lying the patient flat for preoxygenation.
- Treating obesity alone as an indication for rapid sequence.
- Extubating deep or supine in a patient with OSA.
- Sending a patient with severe OSA to an unmonitored bed with opioids.
Rapid-why
Q: Why do obese patients desaturate so quickly? A: FRC falls below closing capacity and oxygen consumption is higher; the oxygen reservoir is smaller and used faster.
Q: Why is obesity hypoventilation syndrome important? A: These patients have daytime hypercapnia, a blunted CO2 drive, pulmonary hypertension and a high risk of postoperative respiratory failure; I check a serum bicarbonate, and 28 mmol/L or more also raises the probability of significant OSA.1
Q: Why is the blood pressure cuff a problem? A: A cuff that is too small overestimates pressure; I use the correct size, a forearm cuff, or an arterial line.
Q: What is the leak test after sleeve gastrectomy? A: The surgeon asks for methylene blue or air insufflation through an orogastric tube, so I coordinate tube placement and withdraw it before stapling.
Numbers to know
| Item | Value |
|---|---|
| Class III obesity | BMI ≥ 40 kg/m² |
| STOP-BANG high risk | 5–8; 3–4 upgraded by BMI > 35, neck > 40 cm, male sex or HCO3 ≥ 281 |
| Preoxygenation target | End-tidal O2 ≥ 0.9 |
| Tidal volume | 6–8 mL/kg ideal body weight |
| PEEP | 8–10 cmH2O or more |
| Ideal body weight (men) | 50 kg + 2.3 kg per inch over 5 ft |
| Sugammadex scalar | Actual body weight: 2, 4 or 16 mg/kg by depth of block4 |
Links
- Obstructive sleep apnea (coming), Anticipated difficult airway and the ASA algorithm, Rapid sequence induction and full stomach, laparoscopy, Pulmonary embolism (coming)
- Atlas: Abdominal free fluid and gastric ultrasound (2026–2027) (coming); Airway ultrasound structures (2027) (coming)
- ASA Practice Guidelines for Perioperative Management of Patients with OSA; ASA Practice Guidelines for Management of the Difficult Airway (2022); Multisociety clinical guidance on GLP-1 receptor agonists (2024)
Sources
- 1.SLEEP STRATEGIES: The flexibility of STOP-Bang Questionnaire to screen for OSA: A practical approach · CHEST Physician (Chung and Nagappa) · blogs.the-hospitalist.org0–2 low, 5–8 high; 3–4 upgraded by BMI >35, neck >40 cm, male sex or HCO3 ≥28 mmol/L.
- 2.New Multi-society Clinical Practice Guidance Released (GLP-1 receptor agonists) · ASA / AGA / ASMBS / ISPCOP / SAGES, 2024 · asahq.org
- 3.Obesity: succinylcholine dosing · OpenAnesthesia · openanesthesia.org
- 4.BRIDION (sugammadex) injection prescribing information · Merck / FDA label · merck.comSection 2.1 dosing on actual body weight; section 8.10 obese patients.
Facts on this page were checked against these sources on Oct 14, 2026. Guidelines change; confirm doses against current institutional protocols.